Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Muir

Showing results (1151-1160 of 1,192) with videos related to

Pageof 120
Sort By:
Stroke|July 16, 2021
Prediction of Outcome and Endovascular Treatment Benefit: Validation and Update of the MR PREDICTS Decision ToolEsmee Venema, Bob Roozenbeek, Maxim J H L Mulder, et al.
Stroke|November 7, 2013
Stroke treatment academic industry roundtable: research priorities in the assessment of neurothrombectomy devicesJeffrey L Saver, Tudor G Jovin, Wade S Smith, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|September 10, 2015
A collaborative sequential meta-analysis of individual patient data from randomized trials of endovascular therapy and tPA vs. tPA alone for acute ischemic stroke: ThRombEctomy And tPA (TREAT) analysis: statistical analysis plan for a sequential meta-analysis performed within the VISTA-Endovascular collaborationRachael L MacIsaac, Pooja Khatri, Martin Bendszus, et al.
The New England Journal of Medicine|May 17, 2018
MRI-Guided Thrombolysis for Stroke with Unknown Time of OnsetGötz Thomalla, Claus Z Simonsen, Florent Boutitie, et al.
Annals of Neurology|April 14, 2019
Direct oral anticoagulants versus vitamin K antagonists after recent ischemic stroke in patients with atrial fibrillationDavid J Seiffge, Maurizio Paciaroni, Duncan Wilson, et al.
European Stroke Journal|April 23, 2019
Rivaroxaban for secondary stroke prevention in patients with embolic strokes of undetermined source: Design of the NAVIGATE ESUS randomized trialRobert G Hart, Mukul Sharma, Hardi Mundl, et al.
Molecular Cell|October 3, 2025
A needed nomenclature for nucleosomesMichael-Christopher Keogh, Genevieve Almouzni, Andrew J Andrews, et al.
Lancet (London, England)|November 11, 2020
Intravenous alteplase for stroke with unknown time of onset guided by advanced imaging: systematic review and meta-analysis of individual patient dataGötz Thomalla, Florent Boutitie, Henry Ma, et al.
JAMA Neurology|October 27, 2025
Thrombolysis With Tenecteplase for Minor Disabling Stroke: Secondary Analysis of the TEMPO-2 Randomized Clinical TrialYiran Zhang, Brian H Buck, Philip A Barber, et al.
The New England Journal of Medicine|May 17, 2018
Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined SourceRobert G Hart, Mukul Sharma, Hardi Mundl, et al.
Pageof 120

Showing results (1151-1160 of 1,192) with videos related to

Sort By:
Pageof 120
Stroke|July 16, 2021
Prediction of Outcome and Endovascular Treatment Benefit: Validation and Update of the MR PREDICTS Decision ToolEsmee Venema, Bob Roozenbeek, Maxim J H L Mulder, et al.
Stroke|November 7, 2013
Stroke treatment academic industry roundtable: research priorities in the assessment of neurothrombectomy devicesJeffrey L Saver, Tudor G Jovin, Wade S Smith, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|September 10, 2015
A collaborative sequential meta-analysis of individual patient data from randomized trials of endovascular therapy and tPA vs. tPA alone for acute ischemic stroke: ThRombEctomy And tPA (TREAT) analysis: statistical analysis plan for a sequential meta-analysis performed within the VISTA-Endovascular collaborationRachael L MacIsaac, Pooja Khatri, Martin Bendszus, et al.
The New England Journal of Medicine|May 17, 2018
MRI-Guided Thrombolysis for Stroke with Unknown Time of OnsetGötz Thomalla, Claus Z Simonsen, Florent Boutitie, et al.
Annals of Neurology|April 14, 2019
Direct oral anticoagulants versus vitamin K antagonists after recent ischemic stroke in patients with atrial fibrillationDavid J Seiffge, Maurizio Paciaroni, Duncan Wilson, et al.
European Stroke Journal|April 23, 2019
Rivaroxaban for secondary stroke prevention in patients with embolic strokes of undetermined source: Design of the NAVIGATE ESUS randomized trialRobert G Hart, Mukul Sharma, Hardi Mundl, et al.
Molecular Cell|October 3, 2025
A needed nomenclature for nucleosomesMichael-Christopher Keogh, Genevieve Almouzni, Andrew J Andrews, et al.
Lancet (London, England)|November 11, 2020
Intravenous alteplase for stroke with unknown time of onset guided by advanced imaging: systematic review and meta-analysis of individual patient dataGötz Thomalla, Florent Boutitie, Henry Ma, et al.
JAMA Neurology|October 27, 2025
Thrombolysis With Tenecteplase for Minor Disabling Stroke: Secondary Analysis of the TEMPO-2 Randomized Clinical TrialYiran Zhang, Brian H Buck, Philip A Barber, et al.
The New England Journal of Medicine|May 17, 2018
Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined SourceRobert G Hart, Mukul Sharma, Hardi Mundl, et al.
Pageof 120